Press Releases
Tissue Engineering and Regenerative Medicine International Society Meeting
Paula Alves, CEO of iBET, was a Keynote Speaker at 6th world congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS2021)
iBET participates in CARDIOPATCH Scientific Meeting
The first annual meeting of the CARDIOPATCH consortium took place on the 21st of October in Toulouse
CARDIOPATCH project highlighted on Exame Informática
CARDIOPATCH project aims to develop an innovative strategy to regenerate damaged cardiac tissue after myocardial infarction
iBET, AbbVie and IPO team-up to improve predictivity of ex-vivo tumour models
Development of innovative and predictive 3D cell models for solid tumors
CARDIOPATCH project highlighted on SIC Notícias
The CARDIOPATCH project was highlighted on National Television – “Exame Informática” (SIC Notícias)
International Society for Extracellular Vesicles Annual Meeting
Researchers from the Stem Cell Bioengineering Lab were present at the International Society for Extracellular Vesicles Annual Meeting (ISEV2021)
Paula Alves awarded with Gold Medal of Merit by Oeiras Municipality
Paula Alves, CEO of iBET and Professor at Universidade NOVA (ITQB, FCT), was awarded with the Gold Medal of Merit by the Oeiras Municipality.
Paula Alves’ profile
Paula Alves, CEO of iBET, was the personality selected to feature in the Profile section of first edition of Vale (Público)
Regenerative medicine at iBET – Exame Informática
iBET role on the international regenerative medicine project BRAVƎ was highlighted in Exame Informática magazine
Vaccine development expertise | Público
iBET expertise on vaccine development was highlighted in the first edition of Vale (Público)
Paula Alves on SIC Notícias | Expresso da Meia Noite
Paula Alves, CEO of iBET, participated in a panel on the National Television show “Expresso da Meia-Noite” (SIC Notícias)
Paula Alves at TEDx Porto Salon
Paula Alves, CEO of iBET, explained how vaccines work and shared insights on the requirements for the approval of vaccines, in a short talk at TEDxPorto Salon.
Paula Alves interview for “Imperdíveis” – Rádio Observador
Paula Alves, CEO of iBET, was interviewed on the national radio show “Imperdíveis” of Observador about her career path and the recent election as international member of the US National Academy of Engineering.
Paula Alves interview on Rádio TSF
Paula Alves, CEO of iBET, was interviewed on the national radio station TSF about current progresses, challenges and perspectives on Vaccine Development.
Kick-off meeting of CARDIOPATCH project
CARDIOPATCH project, funded by the EU Interreg Sudoe Programme, aims to develop an innovative strategy to regenerate damaged tissue after myocardial infarction.
IMI-EU funding to accelerate Advanced Therapy Medicinal Products
iBET participates in ARDAT – Accelerating Research and Innovation for Advanced Therapies project which aims to standardize and accelerate the development of Advanced Therapy Medicinal Products (ATMPs)
Paula Alves interview for RTP / RDP Internacional
Paula Alves, CEO of iBET, was interviewed on International Women’s Day for the national radio show “Holofote” (RTP / RDP International) about her career path on Biochemical Engineering and the importance of diversity and equality in Science.
Paula Alves elected for US National Academy of Engineering
Paula Marques Alves, CEO of iBET, Principal Investigator at ITQB NOVA and Professor at Universidade NOVA de Lisboa, was elected to the US National Academy of Engineering (NAE).
Paula Alves interview on Rádio Renascença
What it takes to produce an effective vaccine
Manuel Carrondo on Innovation Trends on Cell and Gene Therapy
Manuel Carrondo, Vice-President of iBET, shared expert insight on Cell and Gene Therapy in an interview to Cell & Gene Therapy Insights
iBET researchers interviewed on viral-based vaccines
Conversation about current challenges and benefits of process intensification of viral-based vaccines
European project to design a new type of snakebite antivenom based on virus-like particles
iBET role in the project is to establish a GMP-compliant platform for production of customized ADDomers
PURE Project aims to reshape the purification of biopharmaceuticals
iBET participates in PURE, an European project that proposes to develop new sustainable methods of producing biopharmaceuticals
iBET is a partner in TRANSVAC-DS, for an European vaccine infrastructure
iBET is part of “TRANSVAC-DS – Design Study for a European Vaccine Infrastruture”
DiViNe Project is a “success story”
The EU-funded project DiViNe, coordinated by iBET, was recognised by a panel of experts as one of the success stories of European Commission on Research and Innovation.
NESSIE project uses 3D printing to improve vaccine purification step
iBET participates in NESSIE, an ERA-NET project for materials research and innovation aimed at increasing the efficiency of vaccine purification using ceramic 3D printing.
Paula Alves interviewed for “Assim fala a Ciência”
Paula Alves, CEO of iBET, participated in the program “Assim fala a Ciência” supported by Fundação Manuel Francisco dos Santos.
iBET paper on vaccines among most read in Biotechnology and Bioengineering Journal
The publication “Synthetic biology for bioengineering virus‐like particle vaccines“ is in the top 10% most downloaded papers
Serology4COVID consortium creates test for COVID-19 immunity
iBET is part of Serology4COVID, a consortium devoted to create a serological test for the detection of anti-SARS-CoV-2 antibodies.
Paula Alves interview on SIC Notícias | Serology4Covid
Paula Alves, CEO of iBET, was interviewed on the National Television show “Edição da Manhã” (SIC Notícias) about Serology4Covid consortium
JRC report on crossdisciplinarity in the biosciences
Patrícia Gomes-Alves took part in the report "Bridging Across Methods in the Biosciences"
Innovation on vaccine development | SIC Notícias
iBET innovative projects on vaccine development were highlighted on the National Television show “Imagens de Marca” (SIC Notícias channel).
António Roldão’s remarks for Notícias Magazine on novel coronavirus
António Roldão was recently interviewed by Notícias Magazine about the process that goes from identifying a virus to marketing a vaccine.
Master in Vaccinology and Drug Development
António Roldão, Head of the Vaccine Development Lab, was invited coordinator of the “Manufacturing and Quality Process Control” module in the 6th edition of the Master in Vaccinology and Drug Development.
Paula Alves is member of the EURL ECVAM Scientific Advisory Committee
Paula Alves is member of the EURL ECVAM – JRC’s European Union Reference Laboratory for alternatives to animal testing – Scientific Advisory Committee.
iBET is the new member of ACTIP
Being part of ACTIP is a major opportunity to leverage competences in Animal Cell Technology to a superior level
Paula Alves was nominated Associate Editor of Frontiers in Toxicology Journal
Paula Alves was nominated Associate Editor of In Vitro Toxicology, a section of the Frontiers in Toxicology Journal
First WHO International Standard for Lentiviral Vectors
Ana Sofia Coroadinha and Sofia Fernandes participated on a World Health Organization study to produce the first International Standard for Lentiviral Vector integration copy number
Project on regenerative medicine BRAVƎ aims to restore cardiac tissue
A project that aims to develop an advanced biological and personalised ventricular assist device (BioVAD)
Catarina Brito’s interview on Advanced Cell Models
In an interview with BioTechniques, Catarina Brito, head of the Advanced Cell Models Laboratory, comments on the future developments in cell-based disease models.
Paula Alves interviewed by BioTechniques
Paula Alves was interviewed by BioTechniques, regarding her responsabilities as CEO of iBET and Chairperson of ESACT (European Society for Animal Cell Technology).
Bioprocessing for Cell and Gene Therapies on Interview
Manuel Carrondo was interviewed by Oxford Global on Bioprocessing for Cell and Gene Therapies
H2020 project CRUZIVAX
More than 8M€ attributed to H2020 project CRUZIVAX for the development of a vaccine for Chagas disease
30 years of iBET successes in an interview with Paula Alves
Paula Alves, CEO of iBET, was interviewed by “Negócios em Português” (TSF Rádio Notícias), a national radio show dedicated to disseminate Portuguese businesses of excellence.
Paula Alves and Manuel Carrondo talk about iBET in Jornal de Negócios
In the scope of iBET’s 30th anniversary, Paula Alves and Manuel Carrondo were interviewed for Jornal de Negócios.
26th ESACT Meeting
iBET scientists were present at the 26th European Society for Animal Cell Technology (ESACT) Meeting, held in Copenhagen.
New international project to develop a more effective malaria vaccine
A new vaccine for malaria highlighted in several national media: Renascença, Exame Informática, Pontos de Vista
3D cell models for the treatment of neurological disorders
Catarina Brito was interviewed by LUSA about her research on 3D Cell Models. News clipping: Diário de Notícias, Revista Sábado, Visão
Development of bioprocesses for vaccines and viral vectors for gene therapy
Manuel Carrondo’s interview to CELL & GENE THERAPY INSIGHTS
New generation flu vaccine
In an interview to EXPRESSO, Paula Alves disclosed some of the research iBET is doing to develop a new generation Flu vaccine
CARE-MI Project highlighted on SIC Notícias
An innovative clinical trial and the first in Europe with stem cell infusion for cardiac regeneration
iNOVA4Health in an interview with Paula Alves
Paula Alves was interviewed on April 2017 for the radio show "Os Dias do Futuro" - ANTENA 1 about the iNOVA4Health Research Program.
Paula Alves interviewed by ACTIVA
Paula Alves, iBET CEO, was interviewed by ACTIVA magazine, on the 'equation' to reconcile family and career
DiViNe Project on Expresso newspaper
Portugal lead European project on vaccine purification
New drug treatment for Alzheimer's disease
Research carried out on a potential new drug treatment for Alzheimer's disease featured in EXPRESSO
3rd Edition of the ESACT ANIMAL CELL TECHNOLOGY COURSE
September 29 - October 3, 2013 in Llafranc, Costa Brava / Spain
3rd Workshop European Network on Viral Vaccine Processes
25 – 26 November, 2013 in DECHEMA-HAUS, Frankfurt am Main, Germany
Rational design for superior adenovirus producer cell lines
ITQB and iBET researchers uncover what dictates the productivity of adenovirus vectors cell-lines
TSF Mundo Novo interviews researcher Joana Lamego about the Adped Project
Adped project – development of in vitro advanced platforms for oral drug screening and for the monitoring of their absorption in the intestine.
Patricia Gomes-Alves's ‘Lover's Proteome’ wins the 3rd place in the 3rd edition of Proteomics Photography & Graphic Arts contest
The image "Lover's Proteome",represents a combination of interdisciplinary and integrative techniques that are applied to unravel the cardiac stem cells proteome, a work associated with the EU-project "CAREMI"
Researchers from iBET co-author a book alongside with 2012 Nobel Laureate Shinya Yamanaka
Cell Press Reviews: Stem Cells to Model and Treat Disease includes a chapter by researchers from the Animal Cell Technology Unit.
Paula Alves, iBET CEO interviewed on SIC Noticias
On the 25th Anniversary of iBET, Paula Alves, iBET's CEO is interviewed by SIC Noticias and talks about what have been these 25 years and some of the challanges iBET has faced.
Manuel Carrondo interviewed by SIC Noticias - 05.11.2014
Manuel Carrondo was interviewed this week by SIC Noticias concerning the launch of the PSDI Meeting 2014 PROTEIN STRUCTURE DETERMINATION IN INDUSTRY, organized by Merck KGaA, Darmstadt.
